10868492

Source:http://linkedlifedata.com/resource/pubmed/id/10868492

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:10868492	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:10868492	lifeskim:mentions	umls-concept:C0006826	lld:lifeskim
pubmed-article:10868492	lifeskim:mentions	umls-concept:C0005961	lld:lifeskim
pubmed-article:10868492	lifeskim:mentions	umls-concept:C0439858	lld:lifeskim
pubmed-article:10868492	lifeskim:mentions	umls-concept:C1523987	lld:lifeskim
pubmed-article:10868492	pubmed:issue	3	lld:pubmed
pubmed-article:10868492	pubmed:dateCreated	2000-7-14	lld:pubmed
pubmed-article:10868492	pubmed:abstractText	Considerable morbidity and mortality are consequences of the myeloablative chemoradiotherapy utilised in conventional allogeneic marrow transplantation. This has generally restricted such potentially curative treatment to patients <50-55 years with normal organ function. Recent studies suggest that purine-analogue based non-myeloablative regimens are sufficiently immunosuppressive to facilitate allogeneic donor cell engraftment.	lld:pubmed
pubmed-article:10868492	pubmed:language	eng	lld:pubmed
pubmed-article:10868492	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10868492	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:10868492	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10868492	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10868492	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10868492	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:10868492	pubmed:month	Jun	lld:pubmed
pubmed-article:10868492	pubmed:issn	0004-8291	lld:pubmed
pubmed-article:10868492	pubmed:author	pubmed-author:RobertsAA	lld:pubmed
pubmed-article:10868492	pubmed:author	pubmed-author:SvábZZ	lld:pubmed
pubmed-article:10868492	pubmed:author	pubmed-author:GriggAA	lld:pubmed
pubmed-article:10868492	pubmed:author	pubmed-author:SeymourJ FJF	lld:pubmed
pubmed-article:10868492	pubmed:issnType	Print	lld:pubmed
pubmed-article:10868492	pubmed:volume	29	lld:pubmed
pubmed-article:10868492	pubmed:owner	NLM	lld:pubmed
pubmed-article:10868492	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:10868492	pubmed:pagination	308-14	lld:pubmed
pubmed-article:10868492	pubmed:dateRevised	2007-11-15	lld:pubmed
pubmed-article:10868492	pubmed:meshHeading	pubmed-meshheading:10868492...	lld:pubmed
pubmed-article:10868492	pubmed:meshHeading	pubmed-meshheading:10868492...	lld:pubmed
pubmed-article:10868492	pubmed:meshHeading	pubmed-meshheading:10868492...	lld:pubmed
pubmed-article:10868492	pubmed:meshHeading	pubmed-meshheading:10868492...	lld:pubmed
pubmed-article:10868492	pubmed:meshHeading	pubmed-meshheading:10868492...	lld:pubmed
pubmed-article:10868492	pubmed:meshHeading	pubmed-meshheading:10868492...	lld:pubmed
pubmed-article:10868492	pubmed:meshHeading	pubmed-meshheading:10868492...	lld:pubmed
pubmed-article:10868492	pubmed:meshHeading	pubmed-meshheading:10868492...	lld:pubmed
pubmed-article:10868492	pubmed:meshHeading	pubmed-meshheading:10868492...	lld:pubmed
pubmed-article:10868492	pubmed:meshHeading	pubmed-meshheading:10868492...	lld:pubmed
pubmed-article:10868492	pubmed:meshHeading	pubmed-meshheading:10868492...	lld:pubmed
pubmed-article:10868492	pubmed:meshHeading	pubmed-meshheading:10868492...	lld:pubmed
pubmed-article:10868492	pubmed:year	1999	lld:pubmed
pubmed-article:10868492	pubmed:articleTitle	Mini-allografts' for haematological malignancies: an alternative to conventional myeloablative marrow transplantation.	lld:pubmed
pubmed-article:10868492	pubmed:affiliation	Department of Clinical Haematology and Medical Oncology, Royal Melbourne Hospital, Vic.	lld:pubmed
pubmed-article:10868492	pubmed:publicationType	Journal Article	lld:pubmed